Varicella-zoster virus as a live recombinant vaccine

作者: Edward M. Scolnick , Robert S. Lowe , Ronald W. Ellis , Elliott Kieff

DOI:

关键词:

摘要: A vaccine strain of varicella-zoster virus (VZV), tested in clinical trials, is capable preventing chickenpox children. This has been modified by the introduction into its genome heterologous DNA which encodes an immunogenic polypeptide another human pathogen. expressed cells infected recombinant virus. Such VZV useful as a for well pathogens.

参考文章(11)
Russell John Mccandliss, David M. Anderson, Cloned gene and method for making and using the same. ,(1985)
Leonard E. Post, Bernard Roizman, Recombinant method and materials ,(1982)
E. Paoletti, B. R. Lipinskas, C. Samsonoff, S. Mercer, D. Panicali, Construction of live vaccines using genetically engineered poxviruses: biological activity of vaccinia virus recombinants expressing the hepatitis B virus surface antigen and the herpes simplex virus glycoprotein D Proceedings of the National Academy of Sciences of the United States of America. ,vol. 81, pp. 193- 197 ,(1984) , 10.1073/PNAS.81.1.193
David Cavanagh, Viral and bacterial vectors of immunogenes Vaccine. ,vol. 3, pp. 45- 48 ,(1985) , 10.1016/0264-410X(85)90011-8
Bernard Roizman, Herpes simplex virus as a vector ,(1985)
M. Mackett, G. L. Smith, Vaccinia Virus Expression Vectors Journal of General Virology. ,vol. 67, pp. 2067- 2082 ,(1986) , 10.1099/0022-1317-67-10-2067
Bernard Roizman, Leonard E. Post, Recombinant methods and materials ,(1985)